HigherHighs
RankingLoading... stocks
USA
NASDAQ
Healthcare
Biotechnology
LIPO (USA) - Lipella Pharmaceuticals Inc. Common Stock
1W
1M
3M
6M
1Y
2Y
5Y
All
ABOUT Lipella Pharmaceuticals Inc. Common Stock
Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.